Search Tag: leadership team
Biohaven-expands-executive-leadership-team-with-appointment-of-nick-kozauer-m-d
2023 17 Apr
Biohaven Ltd., a global clinical-stage biopharmaceutical company announced that Nick Kozauer, M.D. has joined its executive leadership team as Senior Vice President for Clinical Development and Regulatory Strategy. Dr. Kozauer comes to Biohaven after an accomplished career at the U.S. Food and Drug Administration (FDA) where he served in positions...Read more
Cardurion-pharmaceuticals-appointments-elizabeth-radcliffe-as-chief-financial-officer
2023 19 Jan
Cardurion Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of cardiovascular diseases announced the appointment of Elizabeth Radcliffe as Chief Financial Officer. A seasoned strategic finance leader, Ms. Radcliffe brings to Cardurion more...Read more
Leniobio-announces-appointment-of-new-chief-business-officer-to-leadership-team
2022 06 Sep
LenioBio GmbH, the German life science biotech offering a disruptive protein manufacturing technology announced the appointment of Mr. Jasper Levink to its Leadership Team in the role of Chief Business Officer. In his new role as Chief Business Officer, Mr. Levink will be responsible for driving LenioBio’s business development and business strategy. ...Read more
Health-catalyst-welcomes-two-new-members-to-leadership-team
2022 08 Aug
Health Catalyst, Inc, a leading provider of data and analytics technology and services to healthcare organizations announced the addition of Chief Medical Officer Dr. Melissa Welch and Chief Population Health Officer and Senior Vice President Dr. Edward Sheen to the executive leadership team. Dr. Welch will be the physician voice supporting...Read more
Bexion-pharmaceuticals-inc-welcomes-new-chief-financial-officer
2022 02 Jun
Seasoned BIO/Pharma Executive adds finance, strategic capital access and public market readiness to the management team Bexion Pharmaceuticals, Inc., a mid-stage biopharmaceutical company developing innovative therapies for cancers and chemotherapy induced peripheral neuropathy (CIPN), announced that Ms. Joyce LaViscount has joined the Company’s...Read more